Cargando…
Lipoprotein-X and Lipoprotein-Z Induced Hyperviscosity Syndrome in the Setting of Cholestatic Liver Failure
We describe a case referred for worsening hypercholesterolemia in the setting of atorvastatin and fenofibrate-induced liver injury. The patient reported neurological complaints attributed to hyperviscosity syndrome (induced by lipoprotein-X and lipoprotein-Z). Hepatic recovery was associated with re...
Autores principales: | Waksman, Ori, Cho, Daniel J., Kim, HyoungSup, Otvos, James D., Rosenson, Robert S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588591/ https://www.ncbi.nlm.nih.gov/pubmed/36299645 http://dx.doi.org/10.1016/j.jaccas.2022.09.001 |
Ejemplares similares
-
Blood hyperviscosity in acute and recent COVID-19 infection
por: Shaik, Aleesha, et al.
Publicado: (2022) -
Association of blood viscosity and device-free days among hospitalized patients with COVID-19
por: Waksman, Ori, et al.
Publicado: (2023) -
Association of Blood Viscosity With Mortality Among Patients Hospitalized With COVID-19
por: Choi, Daein, et al.
Publicado: (2022) -
Hyperviscosity syndrome revisited
por: Gangopadhyay, Debasree, et al.
Publicado: (2022) -
Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol‐associated hepatitis
por: Hu, Kunpeng, et al.
Publicado: (2021)